8 in 10 would take part in a trial for others

A nationwide survey of people living with cancer found that helping future patients by advancing research is as important a factor as potentially living longer and feeling better.  

ICTD 2018

Save The Date -18th May. We’ll mark International Clinical Trial Day & launch 2018 Just Ask Your Doctor! campaign thanks to our industry partners.

Stock Photos

Sorry, but you do not have permission to view this content.

Logos

Sorry, but you do not have permission to view this content.

Cancer Trials Ireland opens new breast cancer trial

Cancer Trials Ireland has today (Monday, 27 June 2016) announced that it has opened a cancer trial to test a new treatment for patients with advanced breast cancer which has not responded to currently available treatments.

The trial will test for the first time the use of the new drug copanlisib in combination with trastuzumab to treat advanced HER2-positive (HER2+) breast cancer which has progressed or recurred in patients during or following standard anti-HER2 treatment.

It is expected that up 34 patients will take part in the trial which will be conducted over the next 2-3 years in Beaumont Hospital in Dublin, St Vincent’s University Hospital in Dublin, St. James’s Hospital in Dublin, University Hospital Galway and Cork University Hospital at a cost of approximately 750,000 euro.